Fulcrum Therapeutics FULC
NASDAQ FULC
$3.68 +0.00 (+0.00%)
At close: Oct 23, 2026 · 4:00 PM EDT

Fulcrum Therapeutics (FULC) Cash & Current Investments (2018 - 2026)

Updated

Fulcrum Therapeutics' Cash & Current Investments was $48.47 million in Q2 2026, up 13.8% from $42.59 million a year earlier but down 3.6% from the prior quarter.

Analysis

Fulcrum Therapeutics (FULC) Cash & Current Investments (2018 - 2026) Analysis & Trends

At the end of FY2025, Cash & Current Investments at Fulcrum Therapeutics came in at $197.53 million, up 239.3% from FY2024.

  • Cash & Current Investments shows a five-year compound annual growth rate of 28.2% (FY2020 to FY2025).
  • In earlier years, Cash & Current Investments was $58.21 million in FY2024 (+127.7%), $25.56 million in FY2023 (-27.2%), $35.1 million in FY2022 (-0.9%) and $35.41 million in FY2021 (-37.9%).
  • Quarterly Cash & Current Investments has moved between $25.56 million (Q4 2023) and $197.53 million (Q4 2025) over five years.
  • Compared with a year earlier, Cash & Current Investments has increased for three straight quarters, with growth averaging 57.6% over the last eight quarters.
  • The best year-over-year quarter for Cash & Current Investments over five years was Q4 2025 (growth of 239.3%); the worst was Q1 2022 (a decline of 66.9%).
  • Per Business Quant data, FULC's Cash & Current Investments in the three quarters before Q2 2026 was $50.26 million (Q1 2026), $197.53 million (Q4 2025) and $47.08 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 17.23 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 6.57 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 11.70 Bn
10 Fulcrum Therapeutics 280.27 Mn -63.07 Mn - 48.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 48.47 Mn
Mar 31, 2026 50.26 Mn
Dec 31, 2025 197.53 Mn
Sep 30, 2025 47.08 Mn
Jun 30, 2025 42.59 Mn
Mar 31, 2025 42.18 Mn
Dec 31, 2024 58.21 Mn
Sep 30, 2024 72.63 Mn
Jun 30, 2024 86.70 Mn
Mar 31, 2024 39.95 Mn
Dec 31, 2023 25.56 Mn
Sep 30, 2023 30.08 Mn
Jun 30, 2023 33.97 Mn
Mar 31, 2023 34.73 Mn
Dec 31, 2022 35.10 Mn
Sep 30, 2022 90.94 Mn
Jun 30, 2022 40.15 Mn
Mar 31, 2022 33.31 Mn
Dec 31, 2021 35.41 Mn
Sep 30, 2021 65.47 Mn
API Access

Fulcrum Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=FULC&period=max&api_key=YOUR_API_KEY